EUVIMEDEUVIMED entdecken
Open Access

Late-Onset Sjögren disease: A different clinical entity?

Celil Barlas Cengiz, Tuğba Kahraman Denizhan, Hüseyin Kaplan, Emel Oğuz Kökoğlu, Melih Kızıltepe, Burcu Eren Cengiz, Hanife Oğuz, Abdurrahman Soner Şenel

Sarcoidosis vasculitis and diffuse lung diseases · 27.03.2026 · 43 (1) · 18390-18390

DOI: 10.36141/svdld.2026.18390 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sarcoidosis vasculitis and diffuse lung diseases, erschienen am 27.03.2026. Verfasst von Celil Barlas Cengiz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Erciyes University, Kayseri, Türkiye. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: Sjögren's disease(SjD) exhibits heterogeneous clinical phenotypes influenced by age at onset. This study aimed to evaluate the impact of onset age on the clinical and serological characteristics of SjD in a Turkish cohort. METHODS: We retrospectively analyzed 411 patients diagnosed with SjD between 2013 and 2024, fulfilling the 2002 AECG or 2016 ACR/EULAR criteria. Patients were classified as young-onset ( 60 years; EoSjD). Demographic, clinical, laboratory, and treatment characteristics were compared among groups. RESULTS: The cohort comprised predominantly females (93.4%) with a median age of 55 years. RF positivity was significantly higher in EoSjS (35.5%) compared to YoSjD (27.9%) and AoSjD (19.2%, p=0.007). Inflammatory markers (ESR, CRP) were more frequently elevated in EoSjD. Interstitial lung disease (ILD) prevalence was highest in EoSjD (25.8%, p

Schlagwörter

Sjögren's syndromeage of onsetclinical phenotypeinterstitial lung diseaserheumatoid factoranemiainflammatory markershydroxychloroquineimmunosuppressive therapyelderly patients

Autor:innen und Institutionen

  • Department of Rheumatology, Erciyes University, Kayseri, Türkiye.
  • Department of Rheumatology, Aksaray University Training and Research Hospital, Aksaray, Türkiye.
  • Department of Rheumatology, Kayseri City Education and Research Hospital, Kayseri, Türkiye.
  • Department of Geriatrics, Kayseri City Education and Research Hospital, Kayseri, Türkiye.
  • Department of İnternal Medicine, Erciyes University, Kayseri, Türkiye.

Zitieren

APA

Cengiz, C. B., Kahraman Denizhan, T., Kaplan, H., Oğuz Kökoğlu, E., Kızıltepe, M., Eren Cengiz, B., Oğuz, H., & Şenel, A. S. (2026). Late-Onset Sjögren disease: A different clinical entity?. Sarcoidosis vasculitis and diffuse lung diseases, 43(1), 18390-18390. https://doi.org/10.36141/svdld.2026.18390

Vancouver

Cengiz CB, Kahraman Denizhan T, Kaplan H, Oğuz Kökoğlu E, Kızıltepe M, Eren Cengiz B, et al. Late-Onset Sjögren disease: A different clinical entity?. Sarcoidosis vasculitis and diffuse lung diseases. 2026;43(1):18390-18390. doi:10.36141/svdld.2026.18390

BibTeX
@article{Cengiz2026,
  author = {Cengiz, Celil Barlas and Kahraman Denizhan, Tuğba and Kaplan, Hüseyin and Oğuz Kökoğlu, Emel and Kızıltepe, Melih and Eren Cengiz, Burcu and Oğuz, Hanife and Şenel, Abdurrahman Soner},
  title = {Late-Onset Sjögren disease: A different clinical entity?},
  journal = {Sarcoidosis vasculitis and diffuse lung diseases},
  year = {2026},
  volume = {43},
  number = {1},
  pages = {18390--18390},
  doi = {10.36141/svdld.2026.18390}
}
Kostenlos starten →